IDORSIA AG SF-,05
2,92€
+0,01 (+0,41%)
26.07.2024, 22:59:26 Uhr
WKN: A2DTEB ISIN: CH0363463438 Wertpapiertyp: Aktie Währung: Euro
- 1T
- 1W
- 1M
- 3M
- 6M
- 1J
- 3J
- 5J
- 10J
- Max
Weltmärkte
- DAX ® +118,83 +0,65% 18.417,55
- MDAX ® +165,48 +0,66% 25.116,62
- TecDAX ® +32,09 +0,97% 3.333,28
- E-STOXX 50 ® +51,22 +1,06% 4.862,50
- NASDAQ 100 +193,07 +1,03% 19.023,66
- NIKKEI +201,04 +0,51% 39.780,12
- HANG SENG +13,46 +0,08% 17.021,31
Kursperformance
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Tag | 2,92€ | +0,41% |
| 1 Woche | 2,35€ | +24,26% |
| 1 Monat | 2,13€ | +36,90% |
| 6 Monate | 1,55€ | +88,51% |
| Lfd. Jahr (YTD) | 2,31€ | +26,57% |
| 1 Jahr | 6,37€ | -54,14% |
| 3 Jahre | 23,34€ | -87,49% |
| 5 Jahre | 19,10€ | -84,71% |
Kursdaten
| Kurs | 2,92€ |
| Eröffnung | 2,91€ |
| Geld | 2,84€ |
| Brief | 2,93€ |
| Tages-Hoch | 3,01€ |
| Tages-Tief | 2,84€ |
| 52 Wochen-Hoch | 7,21€ |
| 52 Wochen-Tief | 1,37€ |
| Allzeit-Hoch | 31,65€ |
| Allzeit-Tief | 1,37€ |
Nachrichten
- GlobeNewswire: New data with daridorexant to be presented at SLEEP 2024 - 03.06.2024, 07:00:00 Uhr
- GlobeNewswire: Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024 - 31.05.2024, 07:00:00 Uhr
- GlobeNewswire: Idorsia issues invitation to the 2024 Annual General Meeting of Shareholders - 23.05.2024, 07:00:00 Uhr
- GlobeNewswire: Idorsia announces changes to Idorsia Executive Committee and Board of Directors - 21.05.2024, 07:00:00 Uhr
- GlobeNewswire: Idorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigor - 21.05.2024, 06:50:00 Uhr
- GlobeNewswire: Idorsia announces financial results for the full year of 2023 – Adapting the company to create sustainable value - 21.05.2024, 06:40:00 Uhr
- GlobeNewswire: Invitation to Idorsia's Full Year 2023 and Q1 2024 Financial Reporting webcast and conference call - 14.05.2024, 17:45:00 Uhr
- GlobeNewswire: Bondholders approve amended terms of the 2024 convertible bonds - 06.05.2024, 18:35:00 Uhr
- GlobeNewswire: Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond - 01.05.2024, 18:00:00 Uhr
- GlobeNewswire: JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension - 26.04.2024, 07:00:00 Uhr
